Business Wire

CA-ALTIUM

9.2.2021 03:21:04 CET | Business Wire | Press release

Share
Altium Empowers High School STEM Teachers with a Virtual Electronic Design Curriculum and Tools

In September 2020, Altium LLC, the leading printed circuit board (PCB) software company, launched Upverter Education , a free distance learning initiative to support STEM educators.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005934/en/

“Upverter Education has the opportunity to help high school STEM teachers transition into the virtual classroom. Our goal is to support the next generation of electronics designers of all economic levels by giving them access to free curriculum and professional tools today to prepare them for their innovative careers in the future,” explains Rea Callender, Executive Director of Upverter Education.

The Upverter Education initiative provides the curriculum and resources to guide users through the design, prototyping and manufacturing of electronics engineering concluding with the delivery of students hardware designs. Teachers can utilize the materials to supplement their existing lesson plans, either as standalone units or as a full, 4-6 week educational program.

The program centers around Altium’s Upverter , a free, web-based PCB design tool that’s easy to use in the distance-learning classroom. Upverter’s collaborative and remote capabilities align perfectly with the needs of STEM educators for guiding students through the electronics design process and their exploration of technology and engineering.

Since the launch, the Upverter Education team has formed strategic partnerships with schools around the country and collaborations with leaders in engineering education, including the American Society for Engineering Education, TRYEngineering, First Robotics, and NASA’s Robotics Alliance Project.

Schools within Elk Grove Unified, one of California’s largest school districts, have adopted the Upverter Education program, as well as the North Carolina School of Science and Mathematics (NCSSM), a two-year public residential high school in Durham, NC.

Marshall Massengill, robotics mentor and alumnus of NCSSM, explains how Upverter has been helping him promote remote learning statewide. “Currently with Covid-19, most of our students are spread throughout the state rather than living on campus. Upverter’s collaborative nature is helping transform the team and keep on working, just as we would normally in the lab.” The Upverter Teachers Guide provides step by step instructions for teachers to launch the program.

For Michael Rosales, Engineering and Science teacher at Elk Grove Unified Florin High School, Altium’s education program is already changing the way he teaches Principles of Engineering. “This is perfect for my class already--it allows the kids to look at virtual circuits before they create physical ones, and you can have multiple people working on one circuit together,” Rosales reports.

Educators are currently using the program to teach robotics, engineering, digital electronics design, principles of engineering and STEM intro classes. The Upverter Education team is also supporting high school students working on proposals for NASA’s CubeSat Launch Initiative program, extending the use of Upverter for small satellite payloads.

To see how teachers are using Upverter Education in the classroom, please visit: https://youtu.be/cJu0Qopwk2M

For a comprehensive overview of the Upverter Education distance learning program, please register for this informational webinar , scheduled for February 27, 2021.

About Upverter

Upverter is a free EDA system delivered in a web-browser, which enables students and educators to design, share, and review schematics and printed circuit boards. It provides the ability to generate a bill of materials, Gerber files, and 3D rendering. Upverter is an Altium brand. To learn more about Upverter and Upverter Education, visit https://education.upverter.com/ .

ABOUT ALTIUM

Altium LLC, a global software company headquartered in San Diego, CA is accelerating the pace of innovation through electronics. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.

Social Media:

https://www.facebook.com/AltiumOfficial

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release

The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover

LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release

AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys

Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release

Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A

Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release

Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye